Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

501 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Systematic Review and Meta-Analysis of the Role of Immune Checkpoint Inhibitors (ICI) as Adjuvant Treatment for Localized High-Risk Muscle-Invasive Urothelial Carcinoma (MIUC).
Monteiro FSM, Soares A, Souza VC, Sperandio RC, Grande E, Santoni M, Fay AP, Sasse AD. Monteiro FSM, et al. Among authors: santoni m. Clin Genitourin Cancer. 2022 Oct;20(5):391-398. doi: 10.1016/j.clgc.2022.04.008. Epub 2022 Apr 25. Clin Genitourin Cancer. 2022. PMID: 35595632 Review.
PD-L1 Inhibitors for the Treatment of Prostate Cancer.
Santoni M, Massari F, Cheng L, Cimadamore A, Scarpelli M, Montironi R, Lopez-Beltran A. Santoni M, et al. Curr Drug Targets. 2020;21(15):1558-1565. doi: 10.2174/1389450121666200609142219. Curr Drug Targets. 2020. PMID: 32516098 Review.
Correlation Between Immune-related Adverse Event (IRAE) Occurrence and Clinical Outcome in Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Nivolumab: IRAENE Trial, an Italian Multi-institutional Retrospective Study.
Vitale MG, Pipitone S, Venturelli M, Baldessari C, Porta C, Iannuzzi F, Basso U, Scagliarini S, Zucali PA, Galli L, Rossetti S, Caserta C, Bracarda S, Iacovelli R, Masini C, Cortellini A, Di Girolamo S, Buti S, Fornarini G, Carrozza F, Santoni M, Caputo F, Giaquinta S, Balduzzi S, D'Amico R, Vitale G, Mighali P, Sabbatini R. Vitale MG, et al. Among authors: santoni m. Clin Genitourin Cancer. 2020 Dec;18(6):477-488. doi: 10.1016/j.clgc.2020.05.010. Epub 2020 May 20. Clin Genitourin Cancer. 2020. PMID: 32732112
Impact of Clinicopathological Features on Survival in Patients Treated with First-line Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma: A Meta-analysis of Randomized Clinical Trials.
Rizzo A, Mollica V, Santoni M, Ricci AD, Rosellini M, Marchetti A, Montironi R, Ardizzoni A, Massari F. Rizzo A, et al. Among authors: santoni m. Eur Urol Focus. 2022 Mar;8(2):514-521. doi: 10.1016/j.euf.2021.03.001. Epub 2021 Mar 11. Eur Urol Focus. 2022. PMID: 33714725 Review.
Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study.
Santoni M, Massari F, Grande E, Procopio G, Matrana MR, Rizzo M, De Giorgi U, Basso U, Milella M, Iacovelli R, Aurilio G, Incorvaia L, Buti S, Caffo O, Fornarini G, Carrozza F, Mollica V, Rizzo A, Farag F, Molina-Cerrillo J, Battelli N. Santoni M, et al. Target Oncol. 2021 Sep;16(5):625-632. doi: 10.1007/s11523-021-00828-z. Epub 2021 Aug 2. Target Oncol. 2021. PMID: 34338966
501 results